BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11441433)

  • 1. Central effects of urotensin-II following ICV administration in rats.
    Gartlon J; Parker F; Harrison DC; Douglas SA; Ashmeade TE; Riley GJ; Hughes ZA; Taylor SG; Munton RP; Hagan JJ; Hunter JA; Jones DN
    Psychopharmacology (Berl); 2001 Jun; 155(4):426-33. PubMed ID: 11441433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.
    Gartlon J; Szekeres P; Pullen M; Sarau HM; Aiyar N; Shabon U; Michalovich D; Steplewski K; Ellis C; Elshourbagy N; Duxon M; Ashmeade TE; Harrison DC; Murdock P; Wilson S; Ennaceur A; Atkins A; Heidbreder C; Hagan JJ; Hunter AJ; Jones DN
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):1-14. PubMed ID: 15205870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the urotensin II receptor in the rat central nervous system.
    Jégou S; Cartier D; Dubessy C; Gonzalez BJ; Chatenet D; Tostivint H; Scalbert E; LePrince J; Vaudry H; Lihrmann I
    J Comp Neurol; 2006 Mar; 495(1):21-36. PubMed ID: 16432902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat.
    Gong H; Wang YX; Zhu YZ; Wang WW; Wang MJ; Yao T; Zhu YC
    J Appl Physiol (1985); 2004 Dec; 97(6):2228-35. PubMed ID: 15273242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity.
    Jones DN; Gartlon J; Parker F; Taylor SG; Routledge C; Hemmati P; Munton RP; Ashmeade TE; Hatcher JP; Johns A; Porter RA; Hagan JJ; Hunter AJ; Upton N
    Psychopharmacology (Berl); 2001 Jan; 153(2):210-8. PubMed ID: 11205421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain.
    Gartlon JE; Ashmeade T; Duxon M; Hagan JJ; Jones DN
    Eur J Pharmacol; 2004 Jun; 493(1-3):95-8. PubMed ID: 15189768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of urotensin II and G-protein coupled receptor 14 mRNA in human pheochromocytoma tissues].
    Liu GQ; Zeng ZP; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X; Liu C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):457-60. PubMed ID: 16178439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
    Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
    Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.
    Liu Q; Pong SS; Zeng Z; Zhang Q; Howard AD; Williams DL; Davidoff M; Wang R; Austin CP; McDonald TP; Bai C; George SR; Evans JF; Caskey CT
    Biochem Biophys Res Commun; 1999 Dec; 266(1):174-8. PubMed ID: 10581185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents.
    Matsumoto Y; Abe M; Watanabe T; Adachi Y; Yano T; Takahashi H; Sugo T; Mori M; Kitada C; Kurokawa T; Fujino M
    Neurosci Lett; 2004 Mar; 358(2):99-102. PubMed ID: 15026158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
    Camarda V; Rizzi A; Calò G; Gendron G; Perron SI; Kostenis E; Zamboni P; Mascoli F; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):141-9. PubMed ID: 11819032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.
    Zeng ZP; Liu GQ; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X; Liu C
    Ann N Y Acad Sci; 2006 Aug; 1073():284-9. PubMed ID: 17102097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines.
    Ziltener P; Mueller C; Haenig B; Scherz MW; Nayler O
    J Recept Signal Transduct Res; 2002; 22(1-4):155-68. PubMed ID: 12503613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta.
    Bousette N; Patel L; Douglas SA; Ohlstein EH; Giaid A
    Atherosclerosis; 2004 Sep; 176(1):117-23. PubMed ID: 15306183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues.
    Matsushita M; Shichiri M; Imai T; Iwashina M; Tanaka H; Takasu N; Hirata Y
    J Hypertens; 2001 Dec; 19(12):2185-90. PubMed ID: 11725162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral actions of urotensin-II.
    do Rego JC; Leprince J; Scalbert E; Vaudry H; Costentin J
    Peptides; 2008 May; 29(5):838-44. PubMed ID: 18294732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats.
    Tian L; Li Y; Hua W; Jia Y; Zhou M; Gu Y; Qi J
    Can J Neurol Sci; 2014 Jul; 41(4):498-503. PubMed ID: 24878476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies.
    Matsuzaki I; Takamatsu Y; Moroji T
    Neuropeptides; 1989 Apr; 13(3):147-55. PubMed ID: 2785246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central cardiovascular action of urotensin II in conscious rats.
    Lin Y; Tsuchihashi T; Matsumura K; Abe I; Iida M
    J Hypertens; 2003 Jan; 21(1):159-65. PubMed ID: 12544448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.